51 |
O PAF como regulador endógeno do fenótipo e função das células dendríticas. / PAF as an endogenous modulator of Dendritic Cells phenotype and function.Koga, Marianna Mainardi 16 October 2015 (has links)
Neste trabalho nós mostramos que células dendríticas (DCs) de camundongos BALB/c expressam receptor para o PAF (Fator ativador de Plaquetas) e que sua ativação promove um fenótipo tolerogênico, associado à produção de IL10 e PGE2. O bloqueio do PAF-receptor por antagonistas aumentou a capacidade das DCs induzirem proliferação de linfócitos T. O antagonista WEB2170 potencializou a resposta imune in vivo a concentração de anticorpo IgG2a OVA-específico aumentou 30 vezes no grupo tratado; a concentração de IgG1 foi semelhante nos dois grupos. O bloqueio do PAFR em camundongos imunizados com OVA em adjuvante completo de Freund, aumentou a produção de IgG1 e IgG2a OVA-específicos. Em camundongos imunizados com OVA/alum o antagonista não alterou a produção de IgG1. Estes resultados indicam que a ativação do PAFR em DCs modula a sua função apresentadora de antígenos pela produção de IL10 e PGE2. O bloqueio do PAFR pode ser útil na ativação das DCs em protocolos de vacinação com DCs e/ou como co-adjuvante em protocolos de imunização. / In the present work we show that BALB/c mice dendritic cells (DCs) express the PAF (platelet-activating factor) receptor and that its activation promotes a tolerogenic phenotype via IL10 and PGE2 production. Blocking PAFR by selective antagonists markedly enhanced DCs ability to induce T cell proliferation. The antagonist WEB2170 potentiated the in vivo immune response the IgG2a OVA-specific levels were 30 fold increased in the treated group; IgG1 concentration was similar for both groups. The PAFR blockade in mice immunized with OVA in complete Freunds adjuvant enhanced both IgG1 and IgG2a OVA-specific antibody production. In OVA/alum immunized mice, the antagonist did not change IgG1 production. These results suggest that PAFR activation in DCs modulates their antigen-presenting function through IL10 and PGE2 production. Blocking PAFR may be useful to induce DCs activation in DCs-based vaccination protocols and/or as a co-adjuvant in immunization protocols.
|
52 |
Estudos de efeitos de uma metaloproteinase de veneno ofídico em células de músculo liso vascular: produção de fatores que modulam a migração e proliferação destas células e mecanismos e / Studies on the effects of an ophidian venom metalloproteinase in vascular smooth muscle cells: production of factors that modulate cell migration and proliferation and mechanisms involvedViana, Mariana do Nascimento 04 December 2018 (has links)
As metaloproteinases, abundantes em venenos de serpentes da família Viperidae, apresentam homologia estrutural e funcional com as metaloproteinases de mamíferos (MMPs), cujos níveis estão elevados em doenças de natureza inflamatória, como a aterosclerose. A metaloproteinase BaP1, do veneno da serpente Bothrops asper, apresenta potente atividade inflamatória e constitui ferramenta científica importante para o estudo das ações das MMPs. Durante a aterosclerose, as células de músculo liso vascular (CMLVs) mudam do fenótipo contrátil para sintético, migram para a camada subendotelial do vaso, liberam mediadores inflamatórios e expressam MMPs. No entanto, o papel destas enzimas na resposta inflamatória das CMLVs e a potencial relação deste efeito com a migração das mesmas, não foi esclarecida. Neste estudo, investigou-se os efeitos da BaP1 em CMLVs, quanto à 1) indução da migração; 2) liberação de diferentes classes de mediadores inflamatórios e expressão de moléculas de adesão; 3) indução da mudança fenotípica das CMLVs; 4) expressão e participação de enzimas de síntese de prostaglandinas e de receptores de PGE2 na liberação deste eicosanoide; 5) participação de eicosanoides e da IL-1β na migração e mudança de fenótipo das CMLVs. Os resultados obtidos, a partir dos ensaios de transwell e wound healing, mostraram que a BaP1(50nM) induziu a migração das CMLVs, após 48 h, mas não a proliferação celular, observada pelo ensaio de ciclo celular. Além disso, a metaloproteinase induziu aumento da liberação de PGE2 (1-48h), LTB4 (1-3h), IL-1β (12-24h), MCP-1 (24-48h) e fractalcina (24-48h), mas não de PGI2 e nem TXA2, analisados por ensaios de EIA e multiplex. Ainda, a BaP1 aumentou a expressão proteica de COX-2 (1° h) e de PGESm-1 (4° h), analisada por Western blotting, e expressão gênica das sFLA2-IIA (30 min) e cFLA2-IVA (30 min), verificada por PCR em tempo real, sem alterar os níveis de COX-1, dos receptores EP1, EP2, EP3 e EP4, de ICAM-1 e VCAM-1 e da iFLA2. A intervenção farmacológica com os inibidores de COX-2 ou de FLA2 intracelulares reduziu a liberação de PGE2 induzida pela BaP1. Além disso, o pré-tratamento das células com o inibidor da FLAP e com os antagonistas do receptor de IL-1β ou do receptor EP3 reduziu a migração celular induzida pela BaP1. Esta metaloproteinase também induziu a mudança de fenótipo contrátil para o sintético, das CMLVs, verificada pela diminuição da expressão de α-actina pelo ensaio de citometria de fluxo. A inibição da COX-2 e da FLAP não alterou este efeito. Este conjunto de dados demonstra a capacidade da BaP1 estimular diretamente as CMLVs para migração, liberação de mediadores inflamatórios e a expressão de COX-2, PGESm-1, sFLA2-IIA e cFLA2-IVA. A produção de PGE2 induzida pela BaP1 depende das FLA2s intracelulares, com ativação das vias da COX-1 e -2. A migração das CMLVs, induzida pela BaP1, depende da PGE2 via ativação do receptor EP3, do LTB4 e da IL-1β. Ainda, esta metaloproteinase estimula a mudança fenotípica das CMLVs para o estágio sintético, em que as CMLVs migram e proliferam. Os dados deste estudo, ao demonstrarem que as metaloproteinases contribuem para o desenvolvimento de eventos inflamatórios, em CMLVs, apontam um papel adicional desta classe de enzimas em doenças de natureza inflamatória, como a aterosclerose. / Metalloproteinases are abundant enzymes in Viperidae family snake venoms and exhibit structural and functional homology with mammalian matrix metalloproteinases (MMPs). The levels of these enzymes are incresead in inflammatory diseases, such as atherosclerosis. The BaP1 metalloproteinase from Bothrops asper snake venom presents potent inflammatory activity and constitutes important scientific tool for the study of the actions of MMPs. During atherosclerosis, vascular smooth muscle cells (VSMCs) switch their phenotype from a contractile to a synthetic state, migrate into the subendothelial vessel layer, release inflammatory mediators and express high levels of MMPs. However, the role of these enzymes in the inflammatory response of VSMCs and the potential relationship of this effect with cell migration have not been clarified. In this study, we investigated the effects of BaP1 on CMLVs with focus on: 1) induction of cell migration; 2) release of different classes of inflammatory mediators and protein expression of adhesion molecules; 3) induction of VSMCs phenotype switching; 4) expression and participation of prostaglandin synthesis enzymes and PGE2 receptors in the release of this eicosanoid; 5) participation of eicosanoids and IL-1β in migration and phenotype switching of VSMCs. Results obtained from the transwell and wound healing assays showed that BaP1 (50nM) induced VSMCs migration after 48 h, but not cell proliferation, observed by the cell cycle assay. In addition, this metalloproteinase caused release of PGE2 (1-48h), LTB4 (1-3h), IL-1 (12-24h), MCP-1 (24-48h) and fractalkine (24-48h), but not PGI2 and TXA2, analyzed by EIA and multiplex assays. Furthermore, BaP1 increased protein expression of COX-2 (1 h) and PGESm-1 (4 h), analyzed by western blotting and gene expression of sFLA2-IIA (30 min) and cFLA2-IVA (30 min), evaluated by real-time PCR, without altering COX-1, EP1, EP2, EP3 and EP4, ICAM-1 and VCAM-1 and iFLA2 levels. Pharmacological intervention with COX-2 or intracellular FLA2 inhibitors reduced PGE2 release induced by BaP1. In addition, pretreatment of cells with either a FLAP inhibitor, or IL-1β receptor, or EP3 receptor antagonist reduced cell migration induced by BaP1. This metalloproteinase also induced conversion of contractile VSMCs to an synthetic phenotype, as evidenced by decrease of -actin expression, analyzed by flow cytometry assay. Inhibition of COX-2 and FLAP did not alter this effect. Altogether, these data demonstrate the ability of BaP1 to directly stimulate VSMCs for migration, release of inflammatory mediators and expression of COX-2, PGESm-1, sFLA2-IIA and cFLA2-IVA. PGE2 production induced by BaP1 depends on the intracellular FLA2s, with activation of COX-1 and -2 pathways. VSMCs migration induced by BaP1 depends on PGE2 via EP3 receptor engagement, LTB4 and IL-1β. Furthermore, this metalloproteinase stimulates VSMCs phenotypic switching to a synthetic phenotype, in which these cells migrate and proliferate. These data demonstrate that metalloproteinases can contribute to the development of inflammatory events in VSMCs, evidencing an additional role of this class of enzymes in inflammatory diseases, such as atherosclerosis.
|
53 |
Efeito do exercício de força em diferentes intensidades com volume total similar sobre a dor muscular de início tardio, marcadores de lesão muscular e perfil endócrino. / The effect of different resistance exercise intensities with similar total volume upon delayed on set muscle soreness, muscle damage markers and hormonal profile.Uchida, Marco Carlos 23 June 2008 (has links)
Este estudo compara quatro diferentes intensidades com o volume total similar no exercício supino. Avaliou-se a dor muscular de início tardio (DMIT), atividade de creatina quinase (CK), as concentrações sangüíneas de interleucina (IL)-1<font face=\"symbol\">b, IL-6, fator de necrose tumoral-<font face=\"symbol\">a (TNF-<font face=\"symbol\">a), prostaglandina E2 (PGE2) e o perfil hormonal. A amostra foi composta de soldados do exército brasileiro, divididos em cinco grupos: 50%-1RM, 75%-1RM, 90%-1RM, 110%-1RM e o controle. A DMIT e a atividade plasmática de CK aumentaram significativamente (P<0,05) após a sessão de exercício. A concentração de PGE2 também teve aumento significativo (P<0,05) após a sessão (P<0,05). A concentração plasmática de cortisol após 1h do término do exercício aumentou apenas no grupo 75%-1RM (p < 0,05). Esses resultados sugerem que a intensidade no exercício supino não afeta a magnitude da DMIT, marcadores de lesão muscular, inflamação e na resposta hormonal geral, desde que haja a equalização do volume total, com exceção da concentração plasmática do cortisol, grupo 75%-1RM. / This study compared four different intensities with similar total volume of a bench press exercise for muscle soreness, creatine kinase (CK) activity, interleukin (IL)-1<font face=\"symbol\">b, IL-6, tumor necrosis factor-<font face=\"symbol\">a (TNF-<font face=\"symbol\">a), prostaglandin E2 (PGE2) and hormonal concentrations in the blood. Brazilian Army male soldiers were placed into five groups: 50%-1RM, 75%-1RM, 90%-1RM, and 110%-1RM, and control that did not perform the exercise. Muscle soreness and plasma CK activity increased significantly (p<0.05) after exercise. Serum PGE2 concentration also increased significantly (p<0.05) after exercise. After one hour post exercise cortisol increased in 75%-1RM group, with this response also exceeding the other intensities (p<0.05). These results suggest that the intensity of bench press exercise does not affect the magnitude of muscle soreness and blood markers of muscle damage, inflammation and largely similar hormonal responses, which may be attributed to the equalization of total volume, exception made for the 75%-1RM group for serum cortisol concentration.
|
54 |
Efeitos antagônicos da prostaglandina D2 e prostaglandina E2 na resposta imune durante infecção experimental por Histoplasma capsulatum / Opposite effects of prostaglandin D2 and prostaglandin E2 in immune response during experimental infection by Histoplasma capsulatum.Pereira, Priscilla Aparecida Tartari 30 October 2013 (has links)
O Histoplasma capsulatum é um fungo dimórfico, patogênico e responsável por graves lesões pulmonares. A infecção é adquirida pela inalação de conídios e posterior conversão para leveduras nos alvéolos e bronquíolos, onde são fagocitadas por macrófagos alveolares residentes e leucócitos que migram para o local da infecção. Recentemente, demonstramos que animais infectados com H. capsulatum e tratados com inibidor da síntese de prostaglandinas apresentaram diminuição de carga fúngica nos pulmões e baço, aumento da produção de nitrito e da fagocitose de leveduras por macrófagos alveolares, e maior sobrevivência, quando comparados com os animais somente infectados. Porém, neste estudo não foram determinados quais subtipos de prostaglandinas participam na patogênese da histoplasmose. Vários grupos de pesquisa têm demonstrado que PGD2 e PGE2 podem ter ações biológicas distintas quanto à remoção de microrganismos no hospedeiro. Desta maneira, é fundamental o entendimento do papel da PGD2 e da PGE2 nos mecanismos efetores dos macrófagos na defesa do hospedeiro, especialmente na histoplasmose. Portanto, o objetivo deste estudo foi investigar a participação da PGD2 e PGE2 na infecção experimental por H. capsulatum. Assim, demonstramos que a PGD2 aumentou a fagocitose e mecanismos microbicidas de macrófagos alveolares infectados in vitro com H. capsulatum. Observamos ainda que a 15dPGJ2, metabólito da PGD2, aumentou somente a fagocitose, e PGE2 inibiu os mecanismos efetores do macrófago. Mostramos ainda o aumento de BLT1 em macrófagos alveolares após adição de PGD2, e a possível ligação desta ao BLT1, e de LTB4 em DP2. Além disso, caracterizamos micropartículas de PLGA contendo PGD2 (MS-PGD2), e investigamos seus efeitos. O tamanho, carga elétrica e morfologia das micropartículas foram adequados para um tratamento intranasal e para fagocitose por macrófagos alveolares. As MS-PGD2 foram fagocitadas e capazes de ativar NF-B, e consequentemente, influenciar na produção de nitrito, IL-1, TNF-, IL-6 e TGF-. Com base nestes dados, avaliamos os efeitos do tratamento da MS-PGD2 ou da MS-PGE2 em animais infectados com H. capsulatum. Estas foram administradas via intranasal em animais infectados e tratados ou não com celecoxibe. Verificamos a diminuição da carga fúngica nos pulmões e baço, diminuição do infiltrador celular no espaço broncoalveolar e de citocinas inflamatórias no pulmão após tratamento com MS-PGD2. Contrariamente, após tratamento da MS-PGE2 observamos maior carga fúngica nos pulmões e baço, e aumento da inflamação no tecido e maior produção de IL-10. Além disso, demonstramos que no 21° dia após infecção, referente ao 7° dia após o término do tratamento com MS-PGD2, a carga fúngica manteve-se reduzida nos pulmões, comprovando assim a eficácia deste tratamento. Posteriormente, utilizando inibidores específicos, HQL-79 e CAY10526, mostramos respectivamente o papel protetor da PGD2 e o deletério da PGE2 na histoplasmose. Em conjunto, nossos dados contribuíram para o entendimento das funções antagônicas da PGD2 e PGE2 nesta micose. / Histoplasma capsulatum is a pathogenic dimorphic fungus and responsible for severe pulmonary lesions. Infection is acquired by inhalation of conidia and posterior conversion to yeasts in the alveoli and bronchioles, in which they are phagocyted by resident alveolar macrophages and leukocytes that migrate to the local infection. Recently, we demonstrate that mice infected by H. capsulatum and treated with inhibitor of prostaglandins synthesis presented a decrease in fungal burden in lungs and spleen, increase in nitrite production and uptake of yeasts by alveolar macrophages, and more survival, when compared with animals only infected. However, in this study, it was not determined what subtypes of prostaglandins participate in pathogenesis of histoplasmosis. Many research groups have demonstrated that PGD2 and PGE2 can have different biological effects regarding to microorganisms elimination in the host. Thus, it is primordial the understanding about the role of PGD2 and PGE2 on effector mechanisms of macrophages in host defense, especially in histoplasmosis. Therefore, the aim of this study was to investigate the role of PGD2 and PGE2 on experimental infection by H. capsulatum. So, we verify that PGD2 increased the uptake and microbicidal mechanisms of alveolar macrophages infected in vitro by H. capsulatum. 15dPGJ2, a PGD2 metabolite, increased only the phagocytosis, and PGE2 inhibited the effector mechanisms of macrophages. Among these results, we showed an increase of BLT1 expression on alveolar macrophages after addition of PGD2, and a possible binding of this mediator to BLT1, and of LTB4 to DP2. Later, as tool of therapeutic investigation, we used PGD2 encapsulation in biodegradable polymer, PLGA, in order to preserve its stability. Size, zeta potential and morphology were adequate for a possible intranasal treatment and uptake by alveolar macrophages. MS-PGD2 were phagocyted and able to activate NF-B, and consequently, to modulate nitrite, IL-1, TNF-, IL-6 and TGF- production. In this context, we purpose a treatment of the infection with MS-PGD2, in comparison to treatment with PGE2. MS-PGD2 were administrated via intranasal in infected mice, treated or not with celecoxib. We verify a decrease of fungal burden in lungs and spleen, less cellular infiltrate and decrease of some inflammatory cytokines. In contrast, after treatment of MS-PGE2, we observed greater fungal burden in the lungs and spleen, and an increase of the tissue inflammation and production of IL-10. Furthermore, we show that on day 21 after infection, referring to the 7th day after the treatment with MS-PGD2, fungal burden remained reduced in the lungs, thus proving the effectiveness of the treatment. Subsequently, using specific inhibitors, HQL-79 and CAY10526, respectively show the protective role of PGD2 and in deleterious to PGE2 in histoplasmosis. Together, our data contribute to the understanding of the antagonistic functions of PGD2 and PGE2 in this mycosis.
|
55 |
O PAF como regulador endógeno do fenótipo e função das células dendríticas. / PAF as an endogenous modulator of Dendritic Cells phenotype and function.Marianna Mainardi Koga 16 October 2015 (has links)
Neste trabalho nós mostramos que células dendríticas (DCs) de camundongos BALB/c expressam receptor para o PAF (Fator ativador de Plaquetas) e que sua ativação promove um fenótipo tolerogênico, associado à produção de IL10 e PGE2. O bloqueio do PAF-receptor por antagonistas aumentou a capacidade das DCs induzirem proliferação de linfócitos T. O antagonista WEB2170 potencializou a resposta imune in vivo a concentração de anticorpo IgG2a OVA-específico aumentou 30 vezes no grupo tratado; a concentração de IgG1 foi semelhante nos dois grupos. O bloqueio do PAFR em camundongos imunizados com OVA em adjuvante completo de Freund, aumentou a produção de IgG1 e IgG2a OVA-específicos. Em camundongos imunizados com OVA/alum o antagonista não alterou a produção de IgG1. Estes resultados indicam que a ativação do PAFR em DCs modula a sua função apresentadora de antígenos pela produção de IL10 e PGE2. O bloqueio do PAFR pode ser útil na ativação das DCs em protocolos de vacinação com DCs e/ou como co-adjuvante em protocolos de imunização. / In the present work we show that BALB/c mice dendritic cells (DCs) express the PAF (platelet-activating factor) receptor and that its activation promotes a tolerogenic phenotype via IL10 and PGE2 production. Blocking PAFR by selective antagonists markedly enhanced DCs ability to induce T cell proliferation. The antagonist WEB2170 potentiated the in vivo immune response the IgG2a OVA-specific levels were 30 fold increased in the treated group; IgG1 concentration was similar for both groups. The PAFR blockade in mice immunized with OVA in complete Freunds adjuvant enhanced both IgG1 and IgG2a OVA-specific antibody production. In OVA/alum immunized mice, the antagonist did not change IgG1 production. These results suggest that PAFR activation in DCs modulates their antigen-presenting function through IL10 and PGE2 production. Blocking PAFR may be useful to induce DCs activation in DCs-based vaccination protocols and/or as a co-adjuvant in immunization protocols.
|
56 |
Cervical intraepithelial lesions and integration of human papillomavirus / Intraepiteliniai gimdos kaklelio pokyčiai ir žmogaus papilomos viruso integracijaŠepetienė, Agnė 07 March 2011 (has links)
This dissertation observes the association between human papillomavirus (HPV) integration into the host cell genome and cervical intraepithelial lesions. The aim of this study is to determine how the grade of HPV16 DNA integration into the host cell genome (HPV E2 gene deletion) is related to cervical intraepithelial lesions. 253 women were screened for HPV infection and the majority was diagnosed with HPV type 16. The most frequently determined was HPV grade II integration. No statistically significant difference was defined while analyzing the relations between the status of HPV E2 gene integration and the grade of cervical intraepithelial lesions. The fact that integration of HPV type 16 was determined in low grade cervical squamous intraepithelial lesions or in cases with no intraepithelial lesions shows that virus integration occurs at the early stage of carcinogenesis. It is noteworthy that during the follow-up (secondary visit after 6 month) 50% of HPV positive women were identified with mRNR expression which probably establishes the presence of persistent active HPV infection. The research provided is highly significant for improvement of cervical cancer screening programms. Adjusting Pap smear, HPV DNA detection and determination of other HPV biomarkers (such as E2 gene deletion mRNR), it becomes possible to separate out HPV positive women with no clinical signs, although, belonging to the of high risk group for cervical carcinoma developing. / Disertacijoje nagrinėjama sąsaja tarp žmogaus papilomos viruso (ŽPV) integracijos į gimdos kaklelio epitelio ląstelių genomą ir intraepitelinių gimdos kaklelio pokyčių. Pagrindinis darbo tikslas – nustatyti, kaip 16 tipo ŽPV DNR integracijos laipsnis (ŽPV E2 geno iškrita) susijęs su intraepiteliniais gimdos kaklelio pokyčiais. Ištyrus 253 moteris nustatyta, kad dauguma moterų buvo infekuotos 16 tipo ŽPV. Dažniausiai nustatyta II laipsnio šio tipo ŽPV integracija. Statistiškai reikšmingo skirtumo analizuojant sąsajas tarp ŽPV E2 geno integracijos pobūdžio ir intraepitelinių gimdos kaklelio pokyčių laipsnio nenustatyta. Tai, kad integruotų 16 tipo ŽPV formų nustatyta esant nežymių arba net nesant intraepitelinių gimdos kaklelio pokyčių, rodo, jog viruso integracija yra ankstyvasis kancerogenezės įvykis. Pažymėtina, kad pakartotinio patikrinimo metu 50 proc. ŽPV infekuotų moterų konstatuota mRNR raiška, kas rodo besitęsiančią aktyvią ŽPV infekciją. Atliktas tyrimas yra svarbus gerinant patikros dėl gimdos kaklelio patologijos programas: derinant Pap testą ir ŽPV DNR bei kitų ŽPV žymenų nustatymą (mRNR, E2 geno iškrita) galima atrinkti infekuotas ŽPV moteris, kurioms dar nėra klinikinių požymių, tačiau jos priklauso didelės rizikos susirgti gimdos kaklelio vėžiu grupei.
|
57 |
Intraepiteliniai gimdos kaklelio pokyčiai ir žmogaus papilomos viruso integracija / Cervical intraepithelial lesions and integration of human papillomavirusŠepetienė, Agnė 07 March 2011 (has links)
Disertacijoje nagrinėjama sąsaja tarp žmogaus papilomos viruso (ŽPV) integracijos į gimdos kaklelio epitelio ląstelių genomą ir intraepitelinių gimdos kaklelio pokyčių. Pagrindinis darbo tikslas – nustatyti, kaip 16 tipo ŽPV DNR integracijos laipsnis (ŽPV E2 geno iškrita) susijęs su intraepiteliniais gimdos kaklelio pokyčiais. Ištyrus 253 moteris nustatyta, kad dauguma moterų buvo infekuotos 16 tipo ŽPV. Dažniausiai nustatyta II laipsnio šio tipo ŽPV integracija. Statistiškai reikšmingo skirtumo analizuojant sąsajas tarp ŽPV E2 geno integracijos pobūdžio ir intraepitelinių gimdos kaklelio pokyčių laipsnio nenustatyta. Tai, kad integruotų 16 tipo ŽPV formų nustatyta esant nežymių arba net nesant intraepitelinių gimdos kaklelio pokyčių, rodo, jog viruso integracija yra ankstyvasis kancerogenezės įvykis. Pažymėtina, kad pakartotinio patikrinimo metu 50 proc. ŽPV infekuotų moterų konstatuota mRNR raiška, kas rodo besitęsiančią aktyvią ŽPV infekciją. Atliktas tyrimas yra svarbus gerinant patikros dėl gimdos kaklelio patologijos programas: derinant Pap testą ir ŽPV DNR bei kitų ŽPV žymenų nustatymą (mRNR, E2 geno iškrita) galima atrinkti infekuotas ŽPV moteris, kurioms dar nėra klinikinių požymių, tačiau jos priklauso didelės rizikos susirgti gimdos kaklelio vėžiu grupei. / This dissertation observes the association between human papillomavirus (HPV) integration into the host cell genome and cervical intraepithelial lesions. The aim of this study is to determine how the grade of HPV16 DNA integration into the host cell genome (HPV E2 gene deletion) is related to cervical intraepithelial lesions. 253 women were screened for HPV infection and the majority was diagnosed with HPV type 16. The most frequently determined was HPV grade II integration. No statistically significant difference was defined while analyzing the relations between the status of HPV E2 gene integration and the grade of cervical intraepithelial lesions. The fact that integration of HPV type 16 was determined in low grade cervical squamous intraepithelial lesions or in cases with no intraepithelial lesions shows that virus integration occurs at the early stage of carcinogenesis. It is noteworthy that during the follow-up (secondary visit after 6 month) 50% of HPV positive women were identified with mRNR expression which probably establishes the presence of persistent active HPV infection. The research provided is highly significant for improvement of cervical cancer screening programms. Adjusting Pap smear, HPV DNA detection and determination of other HPV biomarkers (such as E2 gene deletion mRNR), it becomes possible to separate out HPV positive women with no clinical signs, although, belonging to the of high risk group for cervical carcinoma developing.
|
58 |
RECEPTORES EP1 E EP3 MODULAM AS CRISES EPILÉPTICAS INDUZIDAS POR PENTILENOTETRAZOL E ÁCIDO CAÍNICO EM CAMUNDONGOS / EP1 AND EP3 RECEPTORS MODULATE PENTYLENETETRAZOLAND KAINIC ACID-INDUCED SEIZURES IN MICEReschke, Cristina Ruedell 27 June 2013 (has links)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Epilepsy is one of the most common neurologic disorders. It has been suggested that
seizures may be facilitaded by inflammation. PGE2 is one of the most important inflammatory
mediators, and facilitates pentylenetetrazol (PTZ)-induced seizures by stimulating EP1 and
EP3 receptors. However, up to the present moment, no study has investigated whether EP1
and EP3 receptors blocking attenuate seizures induced by convulsants other than PTZ. It is
also unknown whether Na+,K+-ATPase activity alterations are involved in such an effect.
Therefore, in the current study we investigated whether EP1 and EP3 ligands (agonists and
antagonists) modulate PTZ- and kainic acid (KA)-induced seizures, and whether alterations
in Na+,K+-ATPase activity mediate such a protective effect, in mice. EP1 and EP3
antagonists (ONO-8713 and ONO-AE3-240, respectively, 10 Og/kg, s.c.) attenuated PTZ (60
mg/kg, i.p.)- and KA (20 mg/kg, i.p.)-induced seizures. The respective agonists (ONO-DI-004
and ONO-AE-248, 10 Og/kg, s.c.) facilitated seizures in both acute models, and at noneffective
doses, prevented the protective effects of the antagonists. Animals injected with
PTZ presented decreased Na+,K+-ATPase activity in the cerebral cortex and hippocampus.
On the other hand, animals injected with KA presented increased Na+,K+-ATPase activity in
the same cerebral structures at the end of the experiment. These divergent findings suggest
that alterations in Na+,K+-ATPase activity in both acute models depends on the convulsant
agent used and make difficult to establish a relationship between Na+,K+-ATPase activity and
seizure development. Moreover, EP1 and EP3 antagonists administration abolished Na+,K+-
ATPase activity alterations induced by PTZ and KA, in such a way that these alterations
seem to be related more to the presence of ictal phenomenon itself than to the seizure
induction mechanisms. Notwithstanding, the currrent results clearly show that EP1 and EP3
receptors might constitute novel targets for anticonvulsants development, since EP1 and
EP3 decreased seizures, regardless of the convulsant agent used. / A epilepsia é uma das disfunções neurológicas mais comuns. Tem sido sugerido que as
crises epilépticas podem ser facilitadas pela ocorrência de inflamação. A PGE2 é um dos
mediadores inflamatórios mais importantes que, agindo por meio dos receptores EP1 e EP3,
facilita as convulsões induzidas por pentilenotetrazol (PTZ). Contudo, até a presente data,
nenhum estudo investigou, de maneira sistêmica, se a ativação ou bloqueio de receptores
EP1 e EP3 facilitam as convulsões induzidas por outros agentes; tampouco se alterações na
atividade da Na+,K+-ATPase estão envolvidas nesse efeito. Assim, no presente estudo,
investigamos se ligantes (agonistas e antagonistas) de receptores EP1 e EP3 modificam as
crises induzidas por PTZ e ácido caínico (KA), e se tais efeitos estão associados a
alterações na atividade da enzima Na+,K+-ATPase, em camundongos. Os antagonistas EP1
e EP3 (ONO-8713 e ONO-AE3-240, respectivamente, 10 Og/Kg, s.c.) atenuaram as
convulsões induzidas por PTZ (60 mg/Kg, i.p.) e KA (20 mg/Kg). Os seus respectivos
agonistas (ONO-DI-004 e ONO-AE-248 de 10 Og/Kg, s.c.) facilitaram as convulsões em
ambos modelos agudos de crises epilépticas e, em doses não efetivas para gerar crises,
preveniram os efeitos dos antagonistas. Os animais submetidos à administração de PTZ
apresentaram, ao final do experimento, a atividade Na+,K+-ATPásica diminuída no córtex
cerebral e hipocampo. Por outro lado, animais tratados com KA apresentaram um aumento
na atividade Na+,K+-ATPásica nestas mesmas estruturas, que se correlacionou
positivamente com a vigência de status epilepticus no momento do sacrifício. Os achados
divergentes no que diz respeito à alteração da atividade da Na+,K+-ATPase nos dois
modelos de crises agudas sugere que tais alterações estejam relacionadas ao tipo de
agente convulsivante utilizado, e dificultam estabelecer, de forma inequívoca, uma relação
entre atividade desta ATPase e sensibilidade à crises agudas. Ademais, a administração de
antagonistas EP1 e EP3 aboliu as alterações da atividade da Na+,K+-ATPase induzidas tanto
por PTZ como por KA, de tal forma que estas parecem estar mais associadas com o
fenômeno ictal em si, do que com os mecanismos de indução da crise. Contudo, os
resultados mostram de forma clara que os receptores EP1 e EP3 podem se constituir
possíveis novos alvos para o desenvolvimento de drogas antiepilépticas, pois antagonistas
EP1 e EP3 diminuíram as crises, independente do agente convulsivante utilizado.
|
59 |
Protein symmetrization as a novel tool in structural biology / La symétrisation des protéines : un nouvel outil pour la biologie structuraleCoscia, Francesca 04 December 2014 (has links)
La détermination de la structure des protéines à une résolution atomique est cruciale pour la compréhension de leur fonction cellulaire. Actuellement, la cristallographie aux rayons X est la méthode la plus efficace pour la détermination à haute résolution de la structure de protéines monomériques allant 40 et 100 kDa. Par contre, elle est limitée par la croissance de cristaux de bonne qualité, qui est problématique pour nombreuses cibles. La cryo-microscopie électronique (cryoME) permet la détermination structurale à résolution quasi-atomique de larges structures protéiques, de préférence symétrique et en solution. Cependant, les images de cryoME sont très bruitées, car une faible dose d'électrons est appliquée de manière à limiter les dommages d'irradiation. En moyennant des dizaines d'images correspondant à la même orientation moléculaire, le rapport signal sur bruit est amélioré. La combinaison des images moyennées de plusieurs orientations permet l'obtention d'une carte de densité électronique 3D de la molécule d'intérêt. Si la taille et la symétrie de la molécule diminuent, l'analyse cryoME devient de moins en moins précise, il est alors impossible d'analyser des protéines monomériques de taille inférieure à 100 kDa. Le but de ce travail a été de développer une nouvelle approche pour réduire cette limite de poids moléculaire. Elle consiste à fusionner la protéine d'intérêt (cible) à une matrice homo-oligomérique, générant une particule symétrique et de taille importante adaptée à l'analyse par cryoME. Dans cette thèse, nous avons cherché à tester et démontrer la faisabilité de cette approche de symétrisation en utilisant des protéines cibles de structure connue.Pour mettre en place notre étude pilote, nous avons choisi différentes combinaisons de cibles et de matrices connectées par des peptides de liaison (linker) de longueur différentes. Nous avons caractérisé les fusions exprimées en bactéries par microscopie électronique après coloration négative et par plusieurs techniques biophysiques. Grace à ces techniques, nous avons trouvé que la meilleure combinaison est la fusion entre la protéine matrice glutamine synthétase (GS), un 12-mer de symétrie D6 et la cible maltose binding protein (Mbp), connectées par un linker contenant trois alanines, que nous avons appelée « Mag ». En jouant sur la longueur du linker nous avons ensuite sélectionné la fusion la plus compacte pour l'analyse cryoME: MagΔ5. Nous avons obtenu la carte cryoME à 10 Å de MagΔ5, qui présente une bonne corrélation avec les modèles atomiques de Mbp et GS. Plus particulièrement, le site catalytique et quelques hélices α sont identifiables. Ces résultats sont confirmés par l'étude cristallographique que nous avons conduite sur MagΔ5. L'ensemble de ce travail souligne que la présence d'une grande interface d'interactions cible-matrice stabilise la fusion et améliore la résolution en cryoME. Pour la symétrisation d'une cible inconnue, nous envisageons la même procédure expérimentale que celle développée pour MagΔ5. La matrice et le linker les plus adaptés devront être identifiés en utilisant les mêmes méthodes biophysiques.En conclusion, ce travail établit la preuve de concept que la méthode de symétrisation des protéines permet la détermination de la structure de protéines de poids moléculaire inférieur à 100 kDa par cryoME. Cette méthode a le potentiel d'être un nouvel outil prometteur, qui faciliterait l'analyse de cibles résistantes à l'analyse structurale conventionnelle. / Structural determination of proteins at atomic level resolution is crucial for unravelling their function. X-ray crystallography has successfully been used to determine macromolecular structures with sizes ranging from kDa to MDa, and currently remains the most efficient method for the high-resolution structure determination of monomeric proteins within the 40-100 kDa range. However, this method is limited by the ability to grow well diffracting crystals, which is problematic for several targets, such as membrane proteins. Single particle cryo electron microscopy (cryoEM) allows near atomic (3-4Å) resolution structural determination of large, preferably symmetric, assemblies in solution. Biological molecules scatter electrons weakly and, to avoid radiation damage, only low electron doses can be used during imaging. Consequently, raw cryoEM images are extremely noisy. However, averaging many molecular images aligned in the same orientation permits one to increase the signal-to-noise ratio, ultimately allowing the achievement of a 3D density map of the molecule of interest. Nevertheless, as the molecular size and degree of symmetry decrease, the individual images loose adequate features for accurate alignment. Currently, cryoEM analysis is practically impossible for monomeric proteins below ~100 kDa in mass. We propose to circumvent this obstacle by fusing such monomeric target proteins to a homo-oligomeric protein (template), thereby generating a self-assembling particle whose large size and symmetry should facilitate cryoEM analysis. In the present thesis we seek to test and demonstrate the feasibility of this ‘protein symmetrization' approach and to evaluate its usefulness for protein structure determination. To set up the pilot study we combined selected targets of known structure with two templates: Glutamine Synthetase (GS), a 12-mer with D6 symmetry and a helical N-terminus, and the E2 subunit of the pyruvate dehydrogenase complex, a 60-mer with icosahedral symmetry and an unstructured N-terminus. After recombinant production in E.coli we identified by negative stain EM a promising dodecameric chimera for structural analysis, comprising maltose binding protein (Mbp) connected to GS by a tri-alanine linker (denoted “Mag”). In order to optimize sample homogeneity we produced a panel of Mag deletion constructs by sequentially truncating the 17 residues between the Mbp and GS domains. A combination of biophysical techniques (thermal shift assay, dynamic light scattering, size exclusion chromatography) and negative stain EM allowed us to select the best candidate for cryoEM analysis, MagΔ5. By enforcing D6 symmetry we obtained a cryoEM map with a resolution of 10Å (FSC 0.5 criterion). The density of the symmetrized 40 kDa Mbp presents shape and features corresponding to the known atomic structure. In particular, the catalytic pocket and specific α-helical elements are distinguishable. The cryoEM map is additionally validated by a 7Å crystal structure of the MagΔ5 oligomer. The presence of a continuous helical connection between target (Mbp) and template (GS) likely contributed to the conformational homogeneity of MagΔ5. Moreover, comparing MagΔ5 with other chimeras studied in this work suggests that a large buried surface area and favorable interactions between the target and template limit the flexibility of the chimera and improve its resolution by cryoEM. For the symmetrization of a target of unknown structure, we envisage proceeding by a trial and error approach by fusing it to a panel of templates with helical termini and different surface properties, and subsequently selecting the best ones using biophysical assays. In conclusion, the present work establishes the proof-of-concept that protein symmetrization can be used for the structure determination of monomeric proteins below 100 kDa by cryoEM, thereby providing a promising new tool for analyzing targets resistant to conventional structural analysis.
|
60 |
Avaliação dos efeitos da administração oral do firocoxib sobre a quebra da barreira hematoaquosa induzida por paracentese em gatos saudáveis e com sorologia positiva para toxoplasmoseSchroder, Deise Cristine 13 March 2015 (has links)
Submitted by Simone Souza (simonecgsouza@hotmail.com) on 2018-05-15T15:58:32Z
No. of bitstreams: 1
DISS_2015_Deise Cristine Schroder.pdf: 1269604 bytes, checksum: b4aaf38792fb2d963d422ec5bfeabadf (MD5) / Approved for entry into archive by Jordan (jordanbiblio@gmail.com) on 2018-05-24T16:46:13Z (GMT) No. of bitstreams: 1
DISS_2015_Deise Cristine Schroder.pdf: 1269604 bytes, checksum: b4aaf38792fb2d963d422ec5bfeabadf (MD5) / Made available in DSpace on 2018-05-24T16:46:13Z (GMT). No. of bitstreams: 1
DISS_2015_Deise Cristine Schroder.pdf: 1269604 bytes, checksum: b4aaf38792fb2d963d422ec5bfeabadf (MD5)
Previous issue date: 2015-03-13 / CAPES / Objetivou-se avaliar a eficácia do firocoxib em impedir a quebra da barreira hematoaquosa em gatos saudáveis e naqueles com sorologia positiva para toxoplasmose. Avaliaram-se trinta e dois gatos divididos em quatro grupos (n=8). Os grupos saudável controle (SC) e toxoplasmose controle (TC) foram compostos respectivamente por gatos saudáveis e com sorologia positiva para toxoplasmose, enquanto os grupos saudável firocoxib (SF) e toxoplasmose firocoxib (TF) foram compostos respectivamente por gatos saudáveis e com sorologia positiva para toxoplasmose que receberam tratamento prévio com firocoxib (5 mg/kg), por via oral, 24 e uma hora antes da indução da uveíte experimental, através da paracentese da câmara anterior. Após indução anestésica colheu-se 0,2 mL de humor aquoso basal. Decorrido uma hora, realizou-se nova paracentese para colheita de 0,2 mL de humor aquoso inflamado. As amostras de humor aquoso foram acondicionadas a -80°C para posterior mensuração dos níveis de prostaglandina E2 (PGE2) e proteínas totais. No humor aquoso dos grupos TC e TF, realizou-se ainda, titulação para anticorpos IgG anti-Toxoplasma gondii. Mediante análise das amostras, observou-se aumento significativo dos níveis de PGE2 e proteína total do humor aquoso basal para o inflamado (p<0,05). No humor aquoso basal, os níveis de PGE2 no grupo TC, assim como os níveis de proteína total nos grupos SF e TF foram significativamente superiores aos demais (p<0,05). Os grupos TC e TF não apresentaram títulos IgG anti-Toxoplasma gondii no humor aquoso basal. No humor aquoso inflamado, os níveis de PGE2 e proteína total, bem como os títulos IgG anti-Toxoplasma gondii, não diferiram significativamente entre os grupos (p>0,05). Admite-se que gatos com títulos de anticorpos IgG anti-Toxoplasma gondii possuem níveis de PGE2 no humor aquoso basal superiores aos apresentados por indivíduos saudáveis. Entretanto, a concentração de PGE2 no humor aquoso destes indivíduos não é suficiente para
ensejar a quebra da barreira hematoaquosa e causar uveíte anterior. O firocoxib não é capaz de evitar a quebra da barreira hematoaquosa em gatos saudáveis e naqueles soropositivos para toxoplasmose. / The objective was to evaluate the efficacy of firocoxib in preventing the blood-aqueous barrier breakdown in healthy cats and those with positive serology for toxoplasmosis. Thirty-two cats divided into four groups (n=8/each). The healthy control (HC) and toxoplasmosis control (TC) groups, were composed respectively of healthy cats and cats with positive serology for toxoplasmosis, while healthy firocoxib (HF) and toxoplasmosis firocoxib (TF) groups, were composed respectively of healthy cats and cats with positive serology for toxoplasmosis who had received previous treatment with orally firocoxib (5 mg/kg), twenty-four and one hour before the experimental induction of uveitis. Under anesthesia 0.2 mL of baseline aqueous humor was collected via aqueocentesis. One hour later, the same procedure was repeated and inflamed aqueous samples were collected. Aqueous samples were conditioned at -80°C for subsequent measurement of the levels of prostaglandin E2 (PGE2) and total proteins. In the aqueous samples of TC and TF groups, anti-Toxoplasma gondii IgG specific antibodies were titrated. PGE2 and total protein levels increased significantly in inflamed aqueous humor in comparison to baseline aqueous samples (p<0.05). At baseline aqueous humor, levels of PGE2 in TC group and total protein in HF and TF groups were increased significantly, in comparison with the other groups (p<0.05). Anti-Toxoplasma gondii IgG specific antibodies were found only in inflamed aqueous humor, and aqueous titers did not change significantly between TC and TF (p=0.1051). Although we have observed that aqueous humor PGE2 levels were significantly higher in seropositive cats in baseline aqueous humor, such increase was not able to break the blood-aqueous barrier and cause anterior uveitis. Firocoxib did not prevent intraocular inflammation after aqueocentesis, in healthy and toxoplasmosis-seropositive cats.
|
Page generated in 0.0286 seconds